Data as of Q4 2025 (Dec 31, 2025)
RARE

ULTRAGENYX PHARMACEUTICAL IN

Institutional Ownership ยท Q4 2025

Filing: Q4 2025

ULTRAGENYX PHARMACEUTICAL IN (RARE) is held by 277 institutional investors with combined holdings of $4.3B. Major holders include Stonepine Capital Managem, VANGUARD GROUP INC, BlackRock, Inc. (BLK).

Institutional Holders
277
Total Value
$4.3B
Ownership %
87.0%